230 related articles for article (PubMed ID: 14984956)
21. Expression of cathepsin B and cystatin C in the human adenohypophysis and in pituitary adenomas.
Yoshimura K; Tsuchida T; Kawamoto K
Oncol Rep; 2000; 7(1):27-31. PubMed ID: 10601586
[TBL] [Abstract][Full Text] [Related]
22. Serum level of cathepsin B and its density in men with prostate cancer as novel markers of disease progression.
Miyake H; Hara I; Eto H
Anticancer Res; 2004; 24(4):2573-7. PubMed ID: 15330217
[TBL] [Abstract][Full Text] [Related]
23. Cystatin C as a potential marker for relapse in patients with non-Hodgkin B-cell lymphoma.
Mulaomerović A; Halilbasić A; Cickusić E; Zavasnik-Bergant T; Begić L; Kos J
Cancer Lett; 2007 Apr; 248(2):192-7. PubMed ID: 16945481
[TBL] [Abstract][Full Text] [Related]
24. Cathepsins (S and B) and their inhibitor Cystatin C in immune cells: modulation by interferon-β and role played in cell migration.
Staun-Ram E; Miller A
J Neuroimmunol; 2011 Mar; 232(1-2):200-6. PubMed ID: 21112096
[TBL] [Abstract][Full Text] [Related]
25. Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells.
Konduri SD; Yanamandra N; Siddique K; Joseph A; Dinh DH; Olivero WC; Gujrati M; Kouraklis G; Swaroop A; Kyritsis AP; Rao JS
Oncogene; 2002 Dec; 21(57):8705-12. PubMed ID: 12483523
[TBL] [Abstract][Full Text] [Related]
26. [Inhibitory effects of antisense MMP-9 oligodeoxynucleotides on invasiveness and adherence of ovarian cancer cells].
Hu XX; Li L; Li DR; Zhang W; Tang BJ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):662-5. PubMed ID: 17274370
[TBL] [Abstract][Full Text] [Related]
27. Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors.
Strojnik T; Kos J; Zidanik B; Golouh R; Lah T
Clin Cancer Res; 1999 Mar; 5(3):559-67. PubMed ID: 10100707
[TBL] [Abstract][Full Text] [Related]
28. Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis.
Werle B; Schanzenbächer U; Lah TT; Ebert E; Jülke B; Ebert W; Fiehn W; Kayser K; Spiess E; Abrahamson M; Kos J
Oncol Rep; 2006 Oct; 16(4):647-55. PubMed ID: 16969475
[TBL] [Abstract][Full Text] [Related]
29. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and secretion of procathepsin B and cystatin C by human bronchial epithelial cells in vitro: modulation of cathepsin B activity by neutrophil elastase.
Burnett D; Abrahamson M; Devalia JL; Sapsford RJ; Davies RJ; Buttle DJ
Arch Biochem Biophys; 1995 Feb; 317(1):305-10. PubMed ID: 7872798
[TBL] [Abstract][Full Text] [Related]
31. Expression of high molecular weight cysteine proteinase inhibitor in ovarian cancer tissues: regulation of cathepsin B expression by placental CPI.
Siewiński M; Saleh Y; Popiela A; Ziółkowski P; Jeleń M; Gryboś M
Biol Chem; 2003 Jul; 384(7):1103-7. PubMed ID: 12956427
[TBL] [Abstract][Full Text] [Related]
32. Modulation of proliferation and chemosensitivity by procathepsin D and its peptides in ovarian cancer.
Bazzett LB; Watkins CS; Gercel-Taylor C; Taylor DD
Gynecol Oncol; 1999 Aug; 74(2):181-7. PubMed ID: 10419729
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of stefin A in human esophageal squamous cell carcinoma cells inhibits tumor cell growth, angiogenesis, invasion, and metastasis.
Li W; Ding F; Zhang L; Liu Z; Wu Y; Luo A; Wu M; Wang M; Zhan Q; Liu Z
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8753-62. PubMed ID: 16361563
[TBL] [Abstract][Full Text] [Related]
34. Enhanced cystatin C and lysosomal protease expression following 6-hydroxydopamine exposure.
Lee DC; Close FT; Goodman CB; Jackson IM; Wight-Mason C; Wells LM; Womble TA; Palm DE
Neurotoxicology; 2006 Mar; 27(2):260-76. PubMed ID: 16414118
[TBL] [Abstract][Full Text] [Related]
35. Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitors.
Bervar A; Zajc I; Sever N; Katunuma N; Sloane BF; Lah TT
Biol Chem; 2003 Mar; 384(3):447-55. PubMed ID: 12715895
[TBL] [Abstract][Full Text] [Related]
36. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway].
Wang HL; Zhang SL; Lu YM; Jiang JY; Zhu XY
Ai Zheng; 2006 May; 25(5):570-5. PubMed ID: 16687076
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of cathepsin B and stefin A expression in Gleason pattern 3+3 (score 6) prostate cancer needle biopsies.
Sinha AA; Morgan JL; Wood N; Betre K; Reddy A; Wilson MJ; Ramanani DM
Anticancer Res; 2007; 27(3B):1407-13. PubMed ID: 17595755
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic significance of determining cathepsin B activity in malignant ovarian tumors].
Kozyreva EA; Zhordanina KI; Basalyk LS; Vasil'ev AV
Vopr Med Khim; 1994; 40(1):25-7. PubMed ID: 8122404
[TBL] [Abstract][Full Text] [Related]
39. Determination of cathepsin B expression may offer additional prognostic information for ovarian cancer patients.
Scorilas A; Fotiou S; Tsiambas E; Yotis J; Kotsiandri F; Sameni M; Sloane BF; Talieri M
Biol Chem; 2002; 383(7-8):1297-303. PubMed ID: 12437120
[TBL] [Abstract][Full Text] [Related]
40. Cathepsin D protein levels in colorectal tumors: divergent expression patterns suggest complex regulation and function.
Iacobuzio-Donahue C; Shuja S; Cai J; Peng P; Willett J; Murnane MJ
Int J Oncol; 2004 Mar; 24(3):473-85. PubMed ID: 14767531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
